The arrival of SARS-CoV-2-neutralizing antibodies in a currently available commercial immunoglobulin

J Allergy Clin Immunol. 2022 Jun;149(6):1958-1959. doi: 10.1016/j.jaci.2022.03.026. Epub 2022 Apr 22.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Research Support, N.I.H., Extramural

MeSH terms

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • COVID-19*
  • Humans
  • SARS-CoV-2*

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral